Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host Disease and Viral Infections and with Sustained Engraftment.

Judith C. W. Marsh, Vikas Gupta, ZiYi Lim, David Marks, Edward C. Gordon-Smith, Ghulam J. Mufti

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Pages (from-to)446 - 447
    Number of pages2
    JournalBlood
    Volume114
    Issue number22
    Publication statusPublished - 2009

    Cite this